Arcturus Therapeutics Director Magda Marquet Receives 15,000 Stock Options

Magda Marquet, a director of Arcturus Therapeutics Holdings Inc., was granted 15,000 stock options on June 5, 2026, with an exercise price of $7.30 per share. The options represent her 2026 annual grant as a board member and vest monthly over a one-year period from the grant date. The options expire on June 5, 2036. This Form 4 filing reports the acquisition of derivative securities by a company insider, which is a routine disclosure for director compensation. The filing was signed by attorney-in-fact Ilan Katz on June 15, 2026, and covers the transaction date of June 5, 2026.